Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.711. It has been cited 21 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0.247
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Institutes of Health
Grant: 2P30AG019610-11
Education and Information Transfer Core
National Institutes of Health
Grant: 5T32GM007276-36
Cellular and Molecular Biology Training Program
National Institutes of Health
Grant: 5U24NS072026-03
National Brain and Tissue Resource for Parkinson's Disease and Related Disorders
UK Research and Innovation
Grant: MC_UU_00018/1
Understanding Signalling Pathways Mutated in Inherited Disorders
National Institutes of Health
Grant: 5P30AG072980-02
Arizona Alzheimer's Disease Research Center
NIA NIH HHS
Grant: P30 AG019610
NIA NIH HHS
Grant: P30 AG072980
NIGMS NIH HHS
Grant: T32 GM007276
NINDS NIH HHS
Grant: U24 NS072026
Fields of Study
Keywords
Sustainable Development Goals
Data from: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2driven and idiopathic Parkinson’s disease
Data from: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2driven and idiopathic Parkinson's disease
Data from: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2driven and idiopathic Parkinson's disease